We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+9.14%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$21B
AUM Growth
+$1.82B
Cap. Flow
+$406M
Cap. Flow %
1.93%
Top 10 Hldgs %
18.08%
Holding
144
New
8
Increased
70
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
STE icon
Steris
STE
+$339M
2
PLAN
Anaplan, Inc.
PLAN
+$138M
3
CSGP icon
CoStar Group
CSGP
+$86M
4
MRVI icon
Maravai LifeSciences
MRVI
+$67.7M
5
LESL icon
Leslie's
LESL
+$67.2M

Sector Composition

Rank Sector Weight
1 Healthcare 24.84%
2 Technology 20.7%
3 Industrials 14.5%
4 Consumer Staples 12.97%
5 Financials 12.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMC
51
DELISTED
Altra Industrial Motion Corp
AIMC
$167M 0.79%
2,562,270
-12,935
-0.5% -$823K
MKC icon
52
McCormick & Company Non-Voting
MKC
$14B
$166M 0.79%
1,884,910
+475,965
+34% +$42.4M
ULTA icon
53
Ulta Beauty
ULTA
$21.8B
$166M 0.79%
480,271
-192,440
-29% -$63.1M
CHD icon
54
Church & Dwight Co
CHD
$23.7B
$160M 0.76%
1,873,279
+1,700
+0.1% +$147K
TMX
55
DELISTED
Terminix Global Holdings, Inc.
TMX
$158M 0.75%
3,314,035
+275,280
+9% +$13.5M
CFR icon
56
Cullen/Frost Bankers
CFR
$10.5B
$157M 0.75%
1,401,480
-257,285
-16% -$30.1M
CTLT
57
DELISTED
CATALENT, INC.
CTLT
$152M 0.72%
1,403,430
-5,550
-0.4% -$595K
TNDM icon
58
Tandem Diabetes Care
TNDM
$1.27B
$151M 0.72%
1,546,570
+204,410
+15% +$18.2M
CSII
59
DELISTED
Cardiovascular Systems, Inc.
CSII
$146M 0.7%
3,434,185
-15,445
-0.4% -$604K
QTWO icon
60
Q2 Holdings
QTWO
$3.78B
$146M 0.69%
1,420,060
+8,525
+0.6% +$853K
MRVI icon
61
Maravai LifeSciences
MRVI
$972M
$144M 0.69%
3,455,625
+1,746,410
+102% +$67.7M
SXT icon
62
Sensient Technologies
SXT
$5.22B
$144M 0.68%
1,661,360
-159,930
-9% -$13.6M
WLY icon
63
John Wiley & Sons Class A
WLY
$2.83B
$144M 0.68%
2,386,685
-10,460
-0.4% -$622K
B
64
DELISTED
Barnes Group Inc.
B
$144M 0.68%
2,801,940
+6,965
+0.2% +$361K
LESL icon
65
Leslie's
LESL
$8.33M
$143M 0.68%
259,193
+122,553
+90% +$67.2M
RBA icon
66
RB Global
RBA
$21.5B
$141M 0.67%
2,385,450
-3,510
-0.1% -$216K
ZEN
67
DELISTED
ZENDESK INC
ZEN
$133M 0.63%
924,040
+115,395
+14% +$16.3M
PLAN
68
DELISTED
Anaplan, Inc.
PLAN
$132M 0.63%
+2,473,540
New +$138M
WWW icon
69
Wolverine World Wide
WWW
$1.68B
$131M 0.62%
3,884,515
+20,280
+0.5% +$768K
TENB icon
70
Tenable Holdings
TENB
$3.47B
$130M 0.62%
3,132,810
-10,595
-0.3% -$430K
BLKB icon
71
Blackbaud
BLKB
$1.94B
$129M 0.61%
1,679,585
-14,310
-0.8% -$1.03M
HRL icon
72
Hormel Foods
HRL
$14.2B
$128M 0.61%
2,688,025
-18,190
-0.7% -$866K
UMBF icon
73
UMB Financial
UMBF
$11.3B
$128M 0.61%
1,375,050
-97,925
-7% -$9.3M
INSP icon
74
Inspire Medical Systems
INSP
$1.47B
$128M 0.61%
661,655
+66,315
+11% +$13.2M
VRSK icon
75
Verisk Analytics
VRSK
$27.9B
$128M 0.61%
729,865
+221,990
+44% +$39.4M

Similar funds

Champlain Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Champlain Investment Partners held 144 positions worth $21B, up 9.5% from $19.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Champlain Investment Partners's Q2 2021 filing shows 8 new, 70 increased, 59 reduced and 5 closed positions. Its largest new stake was Steris: 1,685,437 shares worth $348M. The largest sale was Cantel Medical Corporation, an estimated $320M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q2 2021 buy was Steris: 1,685,437 shares worth $348M.
  • Champlain Investment Partners added most to Maravai LifeSciences in Q2 2021, an estimated $67.7M increase.
  • Champlain Investment Partners's biggest Q2 2021 reduction was Ulta Beauty, cutting an estimated $63.1M.
  • Champlain Investment Partners fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $320M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $21B portfolio in Q2 2021.
  • Champlain Investment Partners opened 8 new positions and closed 5 in Q2 2021.
  • Champlain Investment Partners's portfolio value rose 9.5% quarter-over-quarter to $21B.

Based on Champlain Investment Partners's 13F filing for Q2 2021, filed 12 Aug 2021.